Completed NA INTERVENTIONAL 4-arm NCT02727816

Non-dispensing Fitting Study Comparing the Clinical Performance Hydrogel Sphere Design Contact Lenses.

Sponsor: CooperVision, Inc.

Conditions Myopia

Interventions filcon IV I (BC 8.6) filcon IV I (BC 8.7) methafilcon A (BC 8.6) methafilcon A (BC 8.7) ocufilcon D somofilcon A

Updated 12 times since 2017 Last updated: Jul 20, 2017 Started: Apr 30, 2016 Primary completion: May 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Myopia and is currently completed. CooperVision, Inc. leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Completed NA
May 2025 — Sep 2025 [monthly]

Completed NA
Jan 2025 — May 2025 [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA

▶ Show 7 earlier versions

Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Mar 2018 — Jun 2018 [monthly]

Completed NA
Feb 2017 — Mar 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CooperVision, Inc.

Data source: CooperVision International Limited (CVIL)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico